News Image

Nanobiotix to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ

Provided By GlobeNewswire

Last update: May 12, 2025

PARIS and CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in fireside chats at following conference:

Read more at globenewswire.com

NANOBIOTIX SA - ADR

NASDAQ:NBTX (6/12/2025, 8:14:21 PM)

5.76

+0.68 (+13.39%)



Find more stocks in the Stock Screener

Follow ChartMill for more